Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

209.98 -5.46 (-2.53%)
Official Closing Price Updated: 7:00 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,044,727
Open 214.76
Bid (Size) 206.51 (1)
Ask (Size) 213.66 (1)
Prev. Close 215.44
Today's Range 209.73 - 214.86
52wk Range 194.30 - 247.65
Shares Outstanding 146,234,244
Dividend Yield 0.74%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much You Would Have Made Owning ResMed Stock In The Last 10 Years
 
Via Benzinga
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
From ResMed Inc.
Via GlobeNewswire

Performance

YTD
+0.42%
+0.42%
1 Month
-10.43%
-10.43%
3 Month
-0.90%
-0.90%
6 Month
-6.90%
-6.90%
1 Year
+3.20%
+3.20%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Via Benzinga
A Bullish Sign Appears On ResMed's Chart
Via Benzinga
ResMed Earnings Perspective: Return On Capital Employed
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today
Via Benzinga
Expert Ratings for ResMed
Via Benzinga
Electronic Arts, TD SYNNEX And 2 Other Stocks Insiders Are Selling
Via Benzinga
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
From ResMed Inc.
Via GlobeNewswire
What's Going On With ResMed Stock Today
Via Benzinga
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
From ResMed Inc.
Via GlobeNewswire
$1000 Invested In ResMed 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In ResMed 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Earnings Scheduled For April 27, 2023
Via Benzinga
Hopeful Golden Cross Forms On ResMed's Chart
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
Via Benzinga
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
From ResMed Inc.
Via GlobeNewswire
ResMed Chief Administrative Officer and Global General Counsel to Retire
From ResMed Inc.
Via GlobeNewswire
3 Incredible Growth Stocks to Buy Right Now
Via The Motley Fool
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
From ResMed Inc.
Via GlobeNewswire
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
From ResMed Inc.
Via GlobeNewswire
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
From ResMed Inc.
Via GlobeNewswire
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
From ResMed Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.